MedPath

A Study of Oral Venetoclax Tablets and Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy

Phase 3
Active, not recruiting
Conditions
Acute Myeloid Leukemia (AML)
Interventions
Registration Number
NCT04102020
Lead Sponsor
AbbVie
Brief Summary

This study will be conducted in two parts. Part 1 will be the Dose Confirmation portion to determine recommended Phase 3 dose (RPTD) of venetoclax in combination with azacitidine (AZA). Part 3 will be the Dose Finding portion to determine RPTD of venetoclax in combination with AZA. Part 2 and Part 3 Randomization of the study were removed.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
112
Inclusion Criteria
  • Diagnosis of newly diagnosed acute myeloid leukemia (AML).

  • Participant meets the following disease activity criteria:

    • Confirmation of AML by World Health Organization (WHO) criteria (2016) and have confirmed complete remission (CR) or complete remission with incomplete blood count recovery (CRi) following completion of intensive induction and consolidation chemotherapies.
    • Achieved first CR + CRi within 120 days of first dose of study drug or be no more than 75 days since last dose of intensive conventional (including both induction and consolidation) chemotherapies.
    • AML has intermediate or poor risk cytogenetics per National Comprehensive Cancer Network (NCCN) 2016 criteria.
  • Eastern Cooperative Oncology Group (ECOG) performance status <= 2.

  • Participant must have adequate hematologic, renal, and liver function laboratory values as described in the protocol.

Exclusion Criteria
  • History of acute promyelocytic leukemia (APL).
  • History of active central nervous system involvement with acute myeloid leukemia (AML).

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
Part 1: Dose ConfirmationVenetoclaxParticipants will receive venetoclax once daily (QD) (Days 1-28) for up to 24 cycles, azacitidine (AZA) QD on Days 1-5 of each 28 day cycle for up to 6 cycles.
Part 1: Dose ConfirmationAzacitidineParticipants will receive venetoclax once daily (QD) (Days 1-28) for up to 24 cycles, azacitidine (AZA) QD on Days 1-5 of each 28 day cycle for up to 6 cycles.
Part 3 (Dose Finding): Dose EscalationVenetoclaxParticipants will receive venetoclax QD for up to 24 cycles, AZA QD on Days 1 to 14 of each 28-day cycle for up to 24 cycles to determine recommended phase 3 dose (RPTD).
Part 3 (Dose Finding): Dose EscalationAzacitidineParticipants will receive venetoclax QD for up to 24 cycles, AZA QD on Days 1 to 14 of each 28-day cycle for up to 24 cycles to determine recommended phase 3 dose (RPTD).
Part 3 (Dose Finding): Safety ExpansionVenetoclaxParticipants will receive venetoclax QD for up to 24 cycles, AZA QD on Days 1 to 14 of each 28-day cycle for up to 24 cycles at the RPTD.
Part 3 (Dose Finding): Safety ExpansionAzacitidineParticipants will receive venetoclax QD for up to 24 cycles, AZA QD on Days 1 to 14 of each 28-day cycle for up to 24 cycles at the RPTD.
Primary Outcome Measures
NameTimeMethod
Number of Participants With Dose-Limiting Toxicities (DLTs) of Venetoclax in Combination with Azacitidine (AZA) (Part 1)Time from treatment of first participant to 20th participant reaching end of cycle 1, approximately 7 Months

DLTs are any of the hematologic, nonhematologic toxicities, adverse events (AEs) occurring following administration of venetoclax as described in the protocol and evaluated by the Investigator and the sponsor.

Number of Participants With DLTs of Venetoclax in Combination with Oral AZA (Part 3 Dose Finding Portion)Time from treatment of first participant to the 14th patient in Safety Expansion reaching the end of Cycle 1, approximately 16 months.

DLTs are hematologic, nonhematologic toxicities, adverse events (AEs) occurring following administration of venetoclax in combination with oral AZA as described in the protocol and evaluated by the Investigator and the sponsor.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (156)

The John Theurer Cancer /ID# 215191

🇺🇸

Hackensack, New Jersey, United States

University of California, Los Angeles /ID# 219149

🇺🇸

Los Angeles, California, United States

Duplicate_Rush University Medical Center /ID# 218815

🇺🇸

Chicago, Illinois, United States

UPMC Hillman Cancer Ctr /ID# 214051

🇺🇸

Pittsburgh, Pennsylvania, United States

Massachusetts General Hospital /ID# 217307

🇺🇸

Boston, Massachusetts, United States

General Hospital of Athens Laiko /ID# 213869

🇬🇷

Athens, Attiki, Greece

University General Hospital Attikon /ID# 214298

🇬🇷

Athens, Attiki, Greece

University General Hospital of Heraklion PA.G.N.I /ID# 214075

🇬🇷

Heraklion, Kriti, Greece

General University Hospital of Alexandroupolis /ID# 213870

🇬🇷

Alexandroupolis, Greece

General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 213872

🇬🇷

Athens, Greece

Mitchell Cancer Institute /ID# 216443

🇺🇸

Mobile, Alabama, United States

Compassionate Cancer Care Research Group - Fountain Valley /ID# 216156

🇺🇸

Fountain Valley, California, United States

University of Kentucky Markey Cancer Center /ID# 215048

🇺🇸

Lexington, Kentucky, United States

Duplicate_Prisma Health Cancer Institute-Faris Road /ID# 216066

🇺🇸

Greenville, South Carolina, United States

Henan Cancer Hospital /ID# 215566

🇨🇳

Zhengzhou, Henan, China

Box Hill Hospital /ID# 217622

🇦🇺

Box Hill, Victoria, Australia

Perth Blood Institute Ltd /ID# 217531

🇦🇺

Nedlands, Western Australia, Australia

Tongji Hospital Tongji Medical College of HUST /ID# 216456

🇨🇳

Wuhan, Hubei, China

Centre Hospitalier de Versailles André Mignot /ID# 215157

🇫🇷

Le Chesnay, France

University General Hospital of Patras /ID# 213871

🇬🇷

RION Patras Achaia, Greece

Duplicate_University of Alberta Hospital - Division of Hematology /ID# 215656

🇨🇦

Edmonton, Alberta, Canada

Oncology Hematology Associates (OHA) - Springfield /ID# 216351

🇺🇸

Springfield, Missouri, United States

Tufts Medical Center /ID# 216110

🇺🇸

Boston, Massachusetts, United States

Tom Baker Cancer Centre /ID# 214625

🇨🇦

Calgary, Alberta, Canada

Wollongong Hospital /ID# 216071

🇦🇺

Wollongong, New South Wales, Australia

Barwon Health /ID# 217921

🇦🇺

Geelong, Victoria, Australia

Juravinski Cancer Centre /ID# 214623

🇨🇦

Hamilton, Ontario, Canada

Shoalhaven District Memorial Hospital /ID# 221973

🇦🇺

Nowra, New South Wales, Australia

London Health Sciences Center- University Hospital /ID# 216055

🇨🇦

London, Ontario, Canada

Chu Angers /Id# 215151

🇫🇷

Angers, France

St George Hospital /ID# 215416

🇦🇺

Kogarah, New South Wales, Australia

Peking University International Hospital /ID# 217439

🇨🇳

Beijing, Guizhou, China

IRCCS Azienda Ospedaliero-Universitaria di Bologna /ID# 213948

🇮🇹

Bologna, Italy

Rabin Medical Center /ID# 239696

🇮🇱

Haifa, Israel

Yamagata University Hospital /ID# 214698

🇯🇵

Yamagata-shi, Yamagata, Japan

MMCC Kommunarka /ID# 215223

🇷🇺

Moscow, Russian Federation

Duplicate_Hopital Henri Mondor /ID# 215159

🇫🇷

Creteil, France

Vas Varmegyei Markusovszky Egyetemi Oktatokorhaz /ID# 215644

🇭🇺

Szombathely, Vas, Hungary

Duplicate_A.O.U. Policlinico G. Rodolico S.Marco- Presidio G.Rodolico /ID# 214802

🇮🇹

Catania, Italy

Ospedale S.Eugenio /ID# 214277

🇮🇹

Rome, Italy

Shaare Zedek Medical Center /ID# 239699

🇮🇱

Jerusalem, Yerushalayim, Israel

Chinese PLA General Hospital /ID# 216286

🇨🇳

Beijing, Beijing, China

Hokkaido University Hospital /ID# 215938

🇯🇵

Sapporo-shi, Hokkaido, Japan

Universitaetsklinikum Halle (Saale) /ID# 221109

🇩🇪

Halle (Saale), Germany

Pan American Center for Oncology Trials, LLC /ID# 214953

🇵🇷

Rio Piedras, Puerto Rico

AOU Citta della Salute e della Scienza di Torino /ID# 214505

🇮🇹

Torino, Piemonte, Italy

Seoul National University Hospital /ID# 213943

🇰🇷

Seoul, Seoul Teugbyeolsi, Korea, Republic of

National Hospital Organization Mito Medical Center /ID# 214699

🇯🇵

Higashi Ibaraki-gun, Ibaraki, Japan

Szabolcs-Szatmar-Bereg Varmegyei Oktatokorhaz /ID# 214425

🇭🇺

Nyiregyhaza, Szabolcs-Szatmar-Bereg, Hungary

Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital /ID# 215680

🇯🇵

Nagoya-shi, Aichi, Japan

Aichi Cancer Center Hospital /ID# 215284

🇯🇵

Nagoya-shi, Aichi, Japan

Semmelweis Egyetem /ID# 214423

🇭🇺

Budapest, Hungary

National Hospital Organization Kyushu Cancer Center /ID# 214841

🇯🇵

Fukuoka-shi, Fukuoka, Japan

Azienda Ospedaliera Universitaria Federico II /ID# 214278

🇮🇹

Napoli, L Aquila, Italy

Universitaetsklinikum Leipzig /ID# 214440

🇩🇪

Leipzig, Sachsen, Germany

ASST Spedali civili di Brescia /ID# 214580

🇮🇹

Brescia, Italy

Somogy Varmegyei Kaposi Mor Oktato Korhaz /ID# 214426

🇭🇺

Kaposvár, Somogy, Hungary

University Hospitals Birmingham NHS Foundation Trust /ID# 215910

🇬🇧

Birmingham, United Kingdom

Hospital Universitario Virgen de la Victoria /ID# 214713

🇪🇸

Malaga, Spain

Nagasaki University Hospital /ID# 214916

🇯🇵

Nagasaki-shi, Nagasaki, Japan

Linkou Chang Gung Memorial Hospital /ID# 213951

🇨🇳

Taoyuan City, Taiwan

P. Hertsen Moscow Oncology Research Institute /ID# 214312

🇷🇺

Moscow, Russian Federation

Hospital Santa Creu i Sant Pau /ID# 214714

🇪🇸

Barcelona, Spain

Hospital Universitario Infanta Leonor /ID# 214843

🇪🇸

Madrid, Spain

Hospital Universitario Fundacion Jimenez Diaz /ID# 214933

🇪🇸

Madrid, Spain

Almazov National Medical Research Centre /ID# 214306

🇷🇺

Sankt-Peterburg, Russian Federation

Duplicate_Instituto Catalan de Oncologia (ICO) L'Hospitalet /ID# 214715

🇪🇸

Hospitalet de Llobregat, Barcelona, Spain

Regional Clinical Hospital of Yaroslavl /ID# 214318

🇷🇺

Yaroslavl, Kurskaya Oblast, Russian Federation

University College London Hospitals NHS Foundation Trust /ID# 215921

🇬🇧

London, United Kingdom

Duplicate_Hospital Universitario Reina Sofia /ID# 214786

🇪🇸

Cordoba, Spain

MD Anderson Madrid /ID# 214477

🇪🇸

Madrid, Spain

Hospital Universitario Ramon y Cajal /ID# 214684

🇪🇸

Madrid, Spain

Barts Health NHS Trust /ID# 215909

🇬🇧

London, London, City Of, United Kingdom

Ankara Univ Medical Faculty /ID# 214239

🇹🇷

Ankara, Turkey

Erciyes University Medical Faculty /ID# 214240

🇹🇷

Kayseri, Turkey

Hospital Universitario 12 de Octubre /ID# 214789

🇪🇸

Madrid, Spain

Hospital Universitario de Navarra /ID# 214788

🇪🇸

Pamplona, Navarra, Spain

Gulhane Askeri Tip Academy /ID# 214242

🇹🇷

Ankara, Adana, Turkey

Klinikum Chemnitz gGmbH /ID# 216073

🇩🇪

Chemnitz, Saarland, Germany

Universitaetsklinikum Giessen und Marburg /ID# 214734

🇩🇪

Marburg, Saarland, Germany

Universitaetsklinikum Schleswig-Holstein Campus Luebeck /ID# 215173

🇩🇪

Lübeck, Schleswig-Holstein, Germany

Karadeniz University /ID# 214241

🇹🇷

Trabzon, Adana, Turkey

Tennessee Oncology-Nashville Centennial /ID# 218757

🇺🇸

Nashville, Tennessee, United States

China Medical University Hospital /ID# 213952

🇨🇳

Taichung, Taiwan

CHU de Nice - Hôpital Archet 1 /ID# 217368

🇫🇷

Nice, Alpes-Maritimes, France

CHU de Nantes - Hotel Dieu /ID# 217367

🇫🇷

Nantes, Pays-de-la-Loire, France

Cardiff & Vale University Health Board /ID# 215906

🇬🇧

Cardiff, Wales, United Kingdom

Centre Hospitalier du Mans /ID# 215148

🇫🇷

Le Mans CEDEX 9, Sarthe, France

Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 213953

🇨🇳

Kaohsiung, Keelung, Taiwan

Leicester Royal Infirmary /ID# 215924

🇬🇧

Leicester, England, United Kingdom

NTT Medical Center Tokyo /ID# 214959

🇯🇵

Shinagawa-ku, Tokyo, Japan

Colorado Blood Cancer Institute /ID# 214280

🇺🇸

Denver, Colorado, United States

West China Hospital, Sichuan University /ID# 216606

🇨🇳

Chengdu, Sichuan, China

Beijing Friendship Hospital /ID# 216455

🇨🇳

Beijing, Beijing, China

Duplicate_Shanghai Tongji Hospital /ID# 218800

🇨🇳

Shanghai, Shanghai, China

Providence Portland Medical Ct /ID# 216231

🇺🇸

Portland, Oregon, United States

Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty /ID# 215525

🇹🇷

Istanbul, Turkey

Hopital Avicenne - APHP /ID# 215152

🇫🇷

Bobigny, Ile-de-France, France

University Hospitals Bristol /ID# 215911

🇬🇧

Bristol, Bristol, City Of, United Kingdom

Guys and St Thomas NHS Foundation Trust /ID# 215908

🇬🇧

London, London, City Of, United Kingdom

Princess Margaret Cancer Centre /ID# 214624

🇨🇦

Toronto, Ontario, Canada

Ottawa Hospital Research Institute /ID# 214627

🇨🇦

Ottawa, Ontario, Canada

McGill University Health Center Research Institute /ID# 215984

🇨🇦

Montreal, Quebec, Canada

Tohoku University Hospital /ID# 214669

🇯🇵

Sendai-shi, Miyagi, Japan

Duplicate_Okayama University Hospital /ID# 214840

🇯🇵

Okayama-shi, Okayama, Japan

St. Alphonsus Regional Medical /ID# 216424

🇺🇸

Boise, Idaho, United States

Duplicate_UMass Chan Medical School /ID# 218163

🇺🇸

Worcester, Massachusetts, United States

Weill Cornell Medical College /ID# 214847

🇺🇸

New York, New York, United States

Rutgers Cancer Institute of New Jersey /ID# 239708

🇺🇸

New Brunswick, New Jersey, United States

St Francis Cancer Center /ID# 216115

🇺🇸

Greenville, South Carolina, United States

Saint Louis University Cancer Center /ID# 218164

🇺🇸

Saint Louis, Missouri, United States

Fox Chase Cancer Center /ID# 239372

🇺🇸

Philadelphia, Pennsylvania, United States

Gibbs Cancer Center & Research /ID# 216192

🇺🇸

Spartanburg, South Carolina, United States

Texas Oncology- Baylor Charles A. Sammons Cancer Center /ID# 214584

🇺🇸

Dallas, Texas, United States

Liverpool Hospital /ID# 215415

🇦🇺

Liverpool, New South Wales, Australia

University of Texas MD Anderson Cancer Center /ID# 225201

🇺🇸

Houston, Texas, United States

Gold coast University Hospital /ID# 214650

🇦🇺

SouthPort, Queensland, Australia

Royal Adelaide Hospital /ID# 238754

🇦🇺

Adelaide, South Australia, Australia

Toowoomba Hospital /ID# 217922

🇦🇺

Toowoomba, Queensland, Australia

Princess Alexandra Hospital /ID# 238753

🇦🇺

Woolloongabba, Queensland, Australia

Guangdong Provincial People's Hospital /ID# 216284

🇨🇳

Guangzhou, Guangdong, China

Nanfang Hospital of Southern Medical University /ID# 215565

🇨🇳

Guangzhou, Guangdong, China

Tangdu Hospital of The Fourth Military Medical University, PLA /ID# 216283

🇨🇳

Xi'an, Shanxi, China

Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 218046

🇨🇳

Wuhan, Hubei, China

Ustav hematologie a krevni transfuze /ID# 215137

🇨🇿

Praha, Czechia

Duplicate_CHU Bordeaux - Hopital Haut Leveque /ID# 215150

🇫🇷

Pessac, Gironde, France

Fakultni Nemocnice Ostrava /ID# 214809

🇨🇿

Ostrava, Praha 17, Czechia

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc /ID# 215558

🇨🇳

Tianjin, Tianjin, China

Fakultni nemocnice Brno /ID# 214807

🇨🇿

Brno, Czechia

The First Affiliated Hospital, Zhejiang University School of Medicine /ID# 215564

🇨🇳

Hangzhou, Zhejiang, China

CHRU Tours - Hopital Bretonneau /ID# 216186

🇫🇷

Tours CEDEX 9, Indre-et-Loire, France

CHRU Lille - Hopital Claude Huriez /ID# 217474

🇫🇷

Lille, Nord, France

Institut Gustave Roussy /ID# 215158

🇫🇷

Villejuif Cedex, Val-de-Marne, France

Centre Hospitalier de la Cote Basque /ID# 216185

🇫🇷

Bayonne, Pyrenees-Atlantiques, France

Debreceni Egyetem-Klinikai Kozpont /ID# 214422

🇭🇺

Debrecen, Hajdu-Bihar, Hungary

Tel Aviv Sourasky Medical Center /ID# 239698

🇮🇱

Tel Aviv, Tel-Aviv, Israel

Hadassah Medical Center-Hebrew University /ID# 239700

🇮🇱

Jerusalem, Yerushalayim, Israel

ASST Grande Ospedale Metropolitano Niguarda /ID# 213946

🇮🇹

Milan, Milano, Italy

Duplicate_Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona /ID# 213944

🇮🇹

Ancona, Italy

Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico /ID# 214826

🇮🇹

Milan, Italy

Azienda Ospedaliera di Rilievo Nazionale Antonio Cardarelli /ID# 213947

🇮🇹

Napoli, Italy

University of Fukui Hospital /ID# 215283

🇯🇵

Yoshida-gun, Fukui, Japan

Kyushu University Hospital /ID# 215286

🇯🇵

Fukuoka-shi, Fukuoka, Japan

Saitama Medical University International Medical Center /ID# 214823

🇯🇵

Hidaka-shi, Saitama, Japan

Osaka Metropolitan University Hospital /ID# 215225

🇯🇵

Osaka-shi, Osaka, Japan

Kindai University Hospital /ID# 214915

🇯🇵

Osakasayama-shi, Osaka, Japan

Pusan National University Hospital /ID# 213941

🇰🇷

Busan, Busan Gwang Yeogsi, Korea, Republic of

Seoul National University Bundang Hospital /ID# 215549

🇰🇷

Seongnam-si, Gyeonggido, Korea, Republic of

Samsung Medical Center /ID# 213940

🇰🇷

Seoul, Seoul Teugbyeolsi, Korea, Republic of

Nizhny Novgorod Regional Clinical Hospital named N.A. Semashko /ID# 214309

🇷🇺

Nizhniy Novgorod, Nizhegorodskaya Oblast, Russian Federation

Clinic of Immunopathology, SRIFCI /ID# 217937

🇷🇺

Novosibirsk, Kurskaya Oblast, Russian Federation

Academician I.P. Pavlov First St. Petersburg State Medical University /ID# 215393

🇷🇺

St. Petersburg, Sankt-Peterburg, Russian Federation

National Taiwan University Hospital /ID# 213939

🇨🇳

Taipei City, Taipei, Taiwan

Duplicate_Norton Cancer Institute /ID# 216401

🇺🇸

Louisville, Kentucky, United States

Tulane Medical Center - New Orleans /ID# 218166

🇺🇸

New Orleans, Louisiana, United States

Ochsner Clinic Foundation-New Orleans /ID# 214583

🇺🇸

New Orleans, Louisiana, United States

© Copyright 2025. All Rights Reserved by MedPath